Dr. Samir Pradeep Shirodkar , MD
Urology • Conroe, TX
1020 Riverwood Ct Ste 330
Conroe, TX 773042975
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 30, 2007; this date does not establish years in practice.
-
Published CMS data list 525,730 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J1071 — Injection, testosterone cypionate, 1 mg: 429,204 service units.
- 87150 — Identification of organisms by genetic analysis, amplified probe technique: 41,149 service units.
- 87801 — Detection test by nucleic acid for multiple organisms, amplified probe(s) technique: 10,288 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 35 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 3,580 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 1,011 prescription fills, including refills.
- Ciprofloxacin Hcl — 416 prescription fills, including refills.
- Cephalexin — 367 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 31 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Urology in Texas (2024, 612 clinicians with data). Median for this group: 1,747. Middle half: 624 to 4,672.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 394,244 in 2020 to 525,730 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1020 Riverwood Ct Ste 330
Conroe, TX 773042975
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in The Woodlands, TX. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Baylor College Of Medicine
2006
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,374 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $4,174,870 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $3,920,659 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
7,448 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$304,316 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $60.08 across 5 records.
By nature of payment
- Food and Beverage: $54.52 across 3 records.
- Education: $5.56 across 2 records.
Reporting-company totals (3 largest of 4)
- Astellas Pharma US Inc: $22.62 across 1 record.
- Sumitomo Pharma America, Inc.: $17.15 across 1 record.
- Boston Scientific Corporation: $14.75 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
20 years (graduated 2006)
CMS Doctors and Clinicians data list 2006 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Shirodkar has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Shirodkar as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Conroe and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Urology in Texas (2024, 612 clinicians with data). Median for this group: 1,747. Middle half: 624 to 4,672.
Too few clinicians listed under Urology in Conroe have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Texas (2024, 612 clinicians with data). Median for this group: $130,714. Middle half: $56,287 to $240,641.
Too few clinicians listed under Urology in Conroe have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Urology in Texas (2024, 612 clinicians with data). Median for this group: $98,137. Middle half: $41,252 to $184,582.
Too few clinicians listed under Urology in Conroe have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Urology in Texas (2024, 674 clinicians with data). Median for this group: 1,247. Middle half: 376 to 2,313.
Too few clinicians listed under Urology in Conroe have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 70% of clinicians listed under Urology in Texas (2024, 674 clinicians with data). Median for this group: $145,258. Middle half: $28,676 to $353,758.
Too few clinicians listed under Urology in Conroe have Medicare Part D data for 2024 to compare.
3 active clinicians are listed under Urology with a practice address in Conroe, TX (968 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 33% from 394,244 in 2020 to 525,730 in 2024.
- 2020: 394,244
- 2021: 458,332
- 2022: 488,828
- 2023: 521,226
- 2024: 525,730
-
Medicare-allowed amount
Medicare-allowed amount increased 311% from $1,015,161 in 2020 to $4,174,870 in 2024.
- 2020: $1,015,161
- 2021: $2,424,225
- 2022: $3,007,204
- 2023: $3,670,242
- 2024: $4,174,870
-
Paid by Medicare
Paid by Medicare increased 402% from $781,050 in 2020 to $3,920,659 in 2024.
- 2020: $781,050
- 2021: $2,192,657
- 2022: $2,744,834
- 2023: $3,441,717
- 2024: $3,920,659
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 73% from 2,068 in 2020 to 3,580 in 2024.
- 2020: 2,068
- 2021: 2,114
- 2022: 2,667
- 2023: 3,045
- 2024: 3,580
-
30-day fills
30-day fills increased 86% from 4,006 in 2020 to 7,448 in 2024.
- 2020: 4,006
- 2021: 4,265
- 2022: 5,384
- 2023: 6,253
- 2024: 7,448
-
Part D drug cost
Part D drug cost increased 38% from $220,473 in 2020 to $304,316 in 2024.
- 2020: $220,473
- 2021: $192,250
- 2022: $488,621
- 2023: $460,468
- 2024: $304,316
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $304.69 in 2021 to $60.08 in 2025.
- 2021: $304.69
- 2022: $92.74
- 2023: $61.71
- 2024: $194.25
- 2025: $60.08
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $60.08.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $22.62 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $17.15 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
Axonics | General | $14.75 |
| Travere Therapeutics, Inc. |
Education
In-kind items and services
|
Thiola | General | $3.01 |
| Travere Therapeutics, Inc. |
Education
In-kind items and services
|
Thiola | General | $2.55 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J1071
Injection, testosterone cypionate, 1 mg
|
429,204 | 136 | $0.07 | $0.02 |
|
87150
Identification of organisms by genetic analysis, amplified probe technique
|
41,149 | 1,224 | $87.98 | $34.14 |
|
87801
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique
|
10,288 | 1,224 | $175.00 | $68.30 |
|
87481
Detection test for candida species (yeast), amplified probe technique
|
6,859 | 1,224 | $100.00 | $34.14 |
|
87798
Detection test by nucleic acid for organism, amplified probe technique
|
6,857 | 1,223 | $44.00 | $34.15 |
|
87640
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
|
3,430 | 1,224 | $88.00 | $34.14 |
|
87641
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique
|
3,430 | 1,224 | $88.00 | $34.14 |
|
87651
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
|
3,430 | 1,224 | $88.03 | $34.14 |
|
87653
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
|
3,430 | 1,224 | $100.31 | $34.14 |
|
87500
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
|
3,429 | 1,224 | $88.00 | $34.14 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
3,227 | 1,187 | $313.00 | $116.50 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
1,907 | 983 | $55.00 | $10.00 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
1,756 | 448 | $213.00 | $82.67 |
|
96372
Injection of drug or substance under skin or into muscle
|
1,493 | 313 | $73.00 | $12.97 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
1,397 | 197 | $2.00 | $0.43 |
|
J9030
Bcg live intravesical instillation, 1 mg
|
1,009 | 15 | $18.50 | $2.74 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
935 | 112 | $214.00 | $71.86 |
|
J1580
Injection, garamycin, gentamicin, up to 80 mg
|
409 | 63 | $5.00 | $2.42 |
|
51700
Simple bladder irrigation and/or instillation
|
375 | 38 | $108.82 | $27.33 |
|
52224
Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm
|
318 | 260 | $1992.00 | $690.85 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
286 | 286 | $314.00 | $100.69 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
186 | 26 | $93.00 | $31.66 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
186 | 26 | $663.00 | $169.76 |
|
81002
Urinalysis, manual test
|
129 | 104 | $11.00 | $3.39 |
|
51741
Electronic assessment of bladder emptying
|
124 | 110 | $90.00 | $12.86 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 1,011 | 81,726 | $17,926.09 | 361 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 416 | 2,924 | $2,273.26 | 313 |
| Cephalexin | Cephalexin | 367 | 28,109 | $5,254.59 | 185 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 186 | 1,938 | $590.46 | 146 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 168 | 3,113 | $3,400.92 | 123 |
| Myrbetriq | Mirabegron | 168 | 10,823 | $156,239.81 | 49 |
| Solifenacin Succinate | Solifenacin Succinate | 166 | 12,230 | $12,230.82 | 76 |
| Finasteride | Finasteride | 135 | 12,090 | $2,125.78 | 48 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 109 | 8,640 | $3,476.74 | 49 |
| Silodosin | Silodosin | 93 | 7,360 | $9,352.93 | 33 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 84 | 436 | $549.56 | 70 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 82 | 549 | $421.61 | 69 |
| Gemtesa | Vibegron | 72 | 4,430 | $67,678.51 | 28 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 69 | 5,410 | $2,715.67 | 33 |
| Testosterone Cypionate | Testosterone Cypionate | 65 | 4,081 | $2,846.70 | 33 |
| Meloxicam | Meloxicam | 50 | 1,664 | $130.35 | 26 |
| Oxybutynin Chloride | Oxybutynin Chloride | 45 | 1,909 | $1,101.55 | — |
| Fluconazole | Fluconazole | 38 | 351 | $382.33 | 31 |
| Doxycycline Hyclate | Doxycycline Hyclate | 32 | 579 | $221.76 | 20 |
| Anastrozole | Anastrozole | 32 | 2,748 | $112.75 | 17 |
| Sildenafil Citrate | Sildenafil Citrate | 29 | 1,040 | $239.78 | — |
| Mirabegron Er | Mirabegron | 26 | 1,080 | $11,886.69 | 12 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 20 | 100 | $101.19 | 18 |
| Tramadol Hcl | Tramadol Hcl | 19 | 104 | $41.69 | 15 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 18 | 1,590 | $287.86 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-10-19NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20111109000304
TX
0244403178
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Secondary Practice Locations
9305 Pinecroft Dr, Suite 104
The Woodlands, TX 773803482
Phone: 9364411005
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
Family Nurse Practitioner (Certified)
Nurse Practitioner - Family
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1020 RIVERWOOD CT STE 330, CONROE, TX 773042975 (Tel: 9362137000)
Registered at PO BOX 749495, ATLANTA, GA 303749495 (Tel: 8559632100)
Additional practice office at 9305 Pinecroft Dr, Suite 104, The Woodlands, TX 773803482
NPI status registered as active in NPPES database
Registered at 9305 PINECROFT DR, SUITE 104, THE WOODLANDS, TX 773803482 (Tel: 9364411005)
Registered at 9305 PINECROFT DR, SUITE 104, THE WOODLANDS, TX 773803482 (Tel: 9364411005)
Recorded as SAMIR SHIRODKAR, MD
Urology (license number reported to NPPES: TX N9644)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Conroe
Healthcare providers in ConroeMailing Address
Po Box 749495
Atlanta, GA 303749495
Phone: 8559632100